Cancer Research CTRC-AACR San Antonio Breast Cancer Symposium  Tumor Immunology: New Perspectives
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 48, 950-953, February 15, 1988]
© 1988 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Raybaud, F.
Right arrow Articles by Birnbaum, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Raybaud, F.
Right arrow Articles by Birnbaum, D.

Detection of a Low Frequency of Activated ras Genes in Human Melanomas Using a Tumorigenicity Assay1

Françoise Raybaud, Tetsuro Noguchi2, Irène Marics, José Adelaide3, Jacqueline Planche, Michèle Batoz, Christian Aubert, Odile de Lapeyriere and Daniel Birnbaum4

Unitè 119 de l'INSERM, 27, Bd Lei Roure, 13009 Marseille, France

We have used an assay combining DNA-mediated gene transfer and tumorigenicity in Swiss athymic mice to look for activated ras genes in solid human sporadic melanomas. This assay can detect ras oncogenes mutated at codons 12, 13, or 61. We examined a panel of 13 independent surgical specimens of primary tumors and metastases. No H- or K-ras oncogenes were detected; an N-ras oncogene, mutated at codon 61, was identified in one of the 13 samples. No N-ras genes mutated at codon 13 were detected. Thus, the tumorigenicity assay detects a low frequency of ras gene activation in melanomas.

1 This research was supported by INSERM and by grants from the Fédération Nationale les Centres de Lutte Contre le Cancer, Association pour la Recherche contre le Cancer, the Fondation pour la Recherche Médicale, and the Comités Départementaux des Bouches du Rhône et des Hautes-Alpes de la Ligue Nationale Français Contre le Cancer.

2 Recipient of a Fellowship from l'Association pour la Recherche sur le Cancer.

3 Supported by a Fellowship from the Comité Départemental des Hautes-Alpes de la Ligue Nationale Français Contre le Cancer.

4 To whom requests for reprints should be addressed.

Received 7/ 1/87. Revised 10/22/87. Accepted 11/11/87.




This article has been cited by other articles:


Home page
Clin. Cancer Res.Home page
K. Omholt, S. Karsberg, A. Platz, L. Kanter, U. Ringborg, and J. Hansson
Screening of N-ras Codon 61 Mutations in Paired Primary and Metastatic Cutaneous Melanomas: Mutations Occur Early and Persist throughout Tumor Progression
Clin. Cancer Res., November 1, 2002; 8(11): 3468 - 3474.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1988 by the American Association for Cancer Research.